Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England


Glaxosmithkline Share Chat (GSK)



Share Price: 1,544.60Bid: 1,543.80Ask: 1,544.40Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.60Spread as %: 0.04%Open: 1,551.80High: 1,558.60Low: 1,539.20Yesterday’s Close: 1,544.60


Share Discussion for Glaxosmithkline


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

father_jack
Posts: 355
Opinion:No Opinion
Price:1,548.80
RE: Tracker Broken
21 Mar '19
Indeed you are correct, best having ADVFN open too, 1549 now
 
AvatarIII
Posts: 39
Opinion:No Opinion
Price:1,546.80
Tracker Broken
21 Mar '19
is it just me or does the tracker on this site say 1525 when the share price has actually shot up to 1547? I hope people aren't relying on this tracker to check the price.
Twonko
Posts: 535
Opinion:No Opinion
Price:1,539.80
Save me
21 Mar '19
Wish the SP wasn’t driven by currency as much as by results. It complicates things too much for my uncomplicated brain, especially with our elected dunces making such a hatstand of Europe.
Dinoken
Posts: 758
Opinion:No Opinion
Price:1,503.20
Tesaro pay back
19 Mar '19
Good test results from Tesaro today. Maybe the purchase price was not as exorbitant as first thought.
driftking27
Posts: 1,466
Opinion:Weak Buy
Price:1,501.60
GSK v FTSE
17 Mar '19
The main thing here, is GSK is cheaper than both FTSE100(18times earnings) & FTSE250 (28 times earnings)

https://www.gsk.com/media/5287/fy-2018-results-announcement.pdf
driftking27
Posts: 1,466
Opinion:Weak Buy
Price:1,501.60
Market movers
16 Mar '19
On a different note, it looks like Biotech and tech are going to keep driving the market for this year and next before interest rates go up again. So that was my thinking..
driftking27
Posts: 1,466
Opinion:Hold
Price:1,501.60
RE: Bought more
16 Mar '19
You could well be right about that. New acquisitions usually hold back companies growth over He first 12-24months, but that’s the time to get in!
Pokerchips
Posts: 7,139
Opinion:No Opinion
Price:1,501.60
RE: Bought more
15 Mar '19
I think the TESARO acquisition is going to hold back EPS for the next 2 years and limit any share price growth to a certain extent...interesting to see the next quarter results and comments on the dividend proposals for 2019
driftking27
Posts: 1,466
Opinion:No Opinion
Price:1,501.60
Bought more
15 Mar '19
Bought £11.5k more here this afternoon and sold half of my MYI stake.

I think tech & Biotech will continue this lead in the markets until we get round all the financial matters regarding US v China & Brexit issue.
johnson36
Posts: 2,951
Opinion:No Opinion
Price:1,514.20
RE: Investing here.
15 Mar '19
bbrinkw

How much annual return are you aiming for ?
Farmertally
Posts: 1,827
Opinion:No Opinion
Price:1,508.80
RE: RE: Puzzled
14 Mar '19
Grayling, sold 40% of holding but did not go too far down the ticker list. GVC - 6 % div plus a fair bit of capital growth if things go ok stateside.

Strange the big director sells just before price fall, only joshing - seems some expect directors to only buy and never sell.

G/L
bbrinkw
Posts: 32
Opinion:No Opinion
Price:1,508.80
RE: Investing here.
11 Mar '19
I would personally consider equal portions of:
GlaxoSmithkline
Legal & General
Bluefield Solar Fundamentals
IT invested in technology stocks
IT invested in smaller companies

The x3 equities will give me 3.00% return on £100k plus the two Investment trusts dividends,
Thus I am invested in drugs, insurance/financials, energy, smaller companies & technology.
When portfolio has made 20k buy into property fund.
DC2007
Posts: 521
Opinion:No Opinion
Price:1,512.40
RE: Investing here.
11 Mar '19
"I want to invest 100k into good dividend stocks"...That's a fair amount of wedge pastyc. How many equities are you planning on spreading it among? What's your timescale/object rate of return/maximum tolerable loss?

ATB
chittybangbang
Posts: 2,158
Opinion:No Opinion
Price:1,509.40
RE: Investing here.
8 Mar '19
I meant being open regarding payment of future dividends. Anyway the China thing was years ago, resolved two years ago. Since then a new CEO and hopefully some changes for the better.

RNS looks very positive
AvatarIII
Posts: 39
Opinion:No Opinion
Price:1,515.80
RE: Investing here.
7 Mar '19
From what I gather that was just the Chinese arm of GSK, not the company as a whole. There were also accusations that bribery in the pharmaceuticals industry in china was rife. The government decided they wanted to put a stop to it, and GSK was unlucky enough to be chosen to be made an example of.

Also the SFO have recently closed their investigation into it, and "concluded no further action [was] required"
Pokerchips
Posts: 7,139
Opinion:No Opinion
Price:1,510.00
RE: Investing here.
7 Mar '19
" At least they (GSK) are honest" ...

I fell off my chair laughing at that one......they werent not so long ago in China , and do have a record oh dodgy goings on abroad ...
chittybangbang
Posts: 2,158
Opinion:No Opinion
Price:1,510.00
RE: Investing here.
7 Mar '19
At least they (GSK) are honest
AllAtSea
Posts: 876
Opinion:No Opinion
Price:1,509.40
RE: Investing here.
7 Mar '19
AZN has an even thinner cover. Is it justified by better growth prospects than GSK?

I can't see why I would want AZN over GSK, other than sp performance.
chittybangbang
Posts: 2,158
Opinion:No Opinion
Price:1,507.40
RE: Investing here.
7 Mar '19
GSK recognises the importance of dividends to shareholders and aims to distribute regular dividend payments that will be determined primarily with reference to the free cash flow generated by the business after funding the investment necessary to support the Group's future growth.
The Board intends to maintain the dividend for 2019 at the current level of 80p per share, subject to any material change in the external environment or performance expectations. Over time, as free cash flow strengthens, it intends to build free cash flow cover of the annual dividend to a target range of 1.25-1.50x, before returning the dividend to growth.

They talk a lot about restructuring, and that has a cost
Pokerchips
Posts: 7,139
Opinion:No Opinion
Price:1,502.20
RE: Investing here.
7 Mar '19
I would take some time and study the accounts and read the last 3 months of RNS to understand the company direction for the next few years....take a look at recent results day videos from the BOD .....and build up an answer to your own question....

The dividend cover here is very, thin with regards free cash flow and they tend to add to the debt when there isnt sufficient to pay the huge dividend bill.

I cant see the dividend rising any time soon, and the company must achieve on its goals to keep the current dividend affordable.... which it is just about managing to do ....but external factors can change things...as we all know

Whilst you might be happy to receive the dividend here, the company itself doesnt get a stronger balance sheet as a result of having to currently afford the expectation ....

The BOD is good and appear to know what they are doing , and where they are heading to....it is more about what external factors which could effect revenues that have to be considered ..such as exchange rates etc ...IMO

Next year is US election year and whoever wins tends to effect Pharma SPs in different ways ....so have an idea of what each side may do to the Pharma Industry in the US ...important to GSK

Whatever you do....dont just park your money in what you think is a good dividend payer.......look at VOD ....see what has happened there !!

The person who will answer your question the best...will be you....

I dont know about any "uproar"with regards recent events ....but...what should be noted is the BOD changed the view that the dividend wouldnt be "progessive" but would be based on results and achieving certain key financial targets ...
I think that made investors uneasy ..as they had come to think the dividend was "safe" no matter how the yearly results were
AvatarIII
Posts: 39
Opinion:No Opinion
Price:1,507.80
RE: Investing here.
4 Mar '19
Dividend has been consistent for the last few years. last time there was talk of reducing the dividend there was uproar and they backed off and continued the 80p/year. It's difficult to say what will happen in the future, especially with brexit looming but based on historical data it's quite a safe stock for dividend.
pastyc
Posts: 1,646
Opinion:No Opinion
Price:1,510.40
Investing here.
3 Mar '19
Hi
I want to invest 100k into good dividend stocks and this is one I'm considering.
Appreciate the LTH advice on whether the current SP is a good entry point and opinion to whether you consider the dividend to be safe, currently yielding just over 5%.
Thanks.
ge0rge123
Posts: 873
Opinion:No Opinion
Price:1,510.40
Iknowverylittke
1 Mar '19
Cannot see that transaction here....have you got level2?...if so do you feel it gives you an edge and improves your trading performance
Thanks
George
AvatarIII
Posts: 39
Opinion:No Opinion
Price:1,504.60
RE: Recovery day?
1 Mar '19
based on historical performance GSK hits it's annual lows in Oct-Dec with occasional smaller dips throughout the rest of the year, slowly recovering and peaking around July. This pattern has repeated since 2012, before which the pattern was reversed, interestingly, but I see no reason for the pattern to reverse again this year.

Brexit is an interesting thing this year though. Difficult to know where it is headed even with only a month to go.
AllAtSea
Posts: 876
Opinion:No Opinion
Price:1,507.20
RE: Recovery day?
1 Mar '19
Must admit I was hoping it's sink a bit more as I do like to buy in as low as possible.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.